Показано 0 из 0
Дата |
---|
20:00 |
02.07.2024 |
28.06.2024 |
21.06.2024 |
20.06.2024 |
17.06.2024 |
14.06.2024 |
13.06.2024 |
12.06.2024 |
11.06.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
0.0051
|
0.02
|
0.0065
|
0.0065
|
0.0133
|
0.0133
|
|
|
18.20
|
3.00
|
0.0051
|
0.0198
|
0.0125
|
0.0125
|
0.0125
|
0.0125
|
|
|
|
1.00
|
0.0051
|
0.0134
|
0.0135
|
0.0125
|
0.0135
|
0.0125
|
|
|
6.95
|
6.00
|
0.0051
|
0.0198
|
0.0136
|
0.0136
|
0.0136
|
0.0136
|
|
|
|
1.00
|
0.0051
|
0.03
|
0.0097
|
0.0097
|
0.0097
|
0.0097
|
|
|
|
1.00
|
0.0065
|
0.02
|
0.0097
|
0.0065
|
0.0097
|
0.0097
|
|
|
78.34
|
10.00
|
0.0051
|
0.0198
|
0.0076
|
0.0069
|
0.0084
|
0.0084
|
|
|
50.43
|
18.00
|
0.0069
|
0.02
|
0.008
|
0.0077
|
0.00875
|
0.00875
|
|
|
49.50
|
8.00
|
0.005
|
0.0249
|
0.0114
|
0.0114
|
0.0114
|
0.0114
|
|
|
|
1.00
|
0.0051
|
0.0198
|
0.0144
|
0.0144
|
0.0144
|
0.0144
|
|
|
|
1.00
|
TC BioPharm is a privately-held, clinical-stage cell therapy company developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease.